These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 1241453)

  • 1. Behavioral supersensitivity to apomorphine and amphetamine after chronic high dose haloperidol treatment.
    Smith RC; Davis JM
    Psychopharmacol Commun; 1975; 1(3):285-93. PubMed ID: 1241453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats.
    Perry JC; Vital MA; Frussa-Filho R; Tufik S; Palermo-Neto J
    Eur Neuropsychopharmacol; 2004 Mar; 14(2):127-33. PubMed ID: 15013028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The time course of the behavioral effects of amphetamine and their reversal by haloperidol in a primate species.
    Ridley RM; Baker HF; Scraggs PR
    Biol Psychiatry; 1979 Oct; 14(5):753-65. PubMed ID: 115505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of central dopaminergic receptors of morphine: effect of haloperidol, apomorphine or benztropine.
    Puri SK; Reddy C; Lal H
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):389-401. PubMed ID: 4735501
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose-response shifts in the behavioural effects of dopamine agonists and antagonists following chronic morphine treatment.
    Overstreet DH; Smee ML; Woolston ME
    Proc West Pharmacol Soc; 1976; 19():248-53. PubMed ID: 1033554
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of angiotensin on the central action of dopamine.
    Braszko J; Wiśniewski K
    Pol J Pharmacol Pharm; 1976; 28(6):667-72. PubMed ID: 1034924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methodone interaction with apomorphine- and amphetamine-induced turning.
    Stratten WP
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):675-8. PubMed ID: 1237160
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
    Pittman KJ; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of chronic levodopa on haloperidol-induced behavioral supersensitivity in the guinea pig.
    Weiner WJ; Carvey P; Nausieda PA; Goetz CG; Klawans HL
    Adv Neurol; 1982; 35():213-9. PubMed ID: 6890754
    [No Abstract]   [Full Text] [Related]  

  • 12. [Behavioral effects of chronic apomorphine, and D-1/D-2 dopamine receptor activities in rats].
    Minematsu N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Jun; 15(3):247-52. PubMed ID: 7584718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
    Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS
    Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensorimotor gating effects produced by repeated dopamine agonists in a paradigm favoring environmental conditioning.
    Feifel D; Priebe K; Johnstone-Miller E; Morgan CJ
    Psychopharmacology (Berl); 2002 Jul; 162(2):138-46. PubMed ID: 12110991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral supersensitivity to methamphetamine following chronic treatment with (--)-sulpiride in the rat.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Boll Soc Ital Biol Sper; 1981 Feb; 57(4):401-6. PubMed ID: 7195265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
    Ushijima I; Noda Y; Mizuki Y; Yamada M
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotypy following acute administration of l-alpha-acetylmethadol (LAAM) in the rat.
    Henderson GL; Westkaemper R
    Proc West Pharmacol Soc; 1975; 18():204-7. PubMed ID: 1237140
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of pyrazolone-5 derivatives on amphetamine-induced hyperthermia and behavioural changes in rats.
    Misterek K; Klimecka H
    Pol J Pharmacol Pharm; 1976; 28(6):593-9. PubMed ID: 1034922
    [No Abstract]   [Full Text] [Related]  

  • 20. Behavioral effects of apomorphine during development of rats.
    Brus R; Herman ZS; Jamrozik Z
    Acta Physiol Pol; 1977; 28(3):243-6. PubMed ID: 561515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.